Skip to main content
. 2017 Apr 13;8(25):41474–41486. doi: 10.18632/oncotarget.17102

Figure 2.

Figure 2

Kaplan-Meier curves comparing progression-free survival (PFS) and overall survival (OS) on EGFR-TKIs between patients with and without the BIM deletion in the (A, B) whole cohort, (C, D) Korean cohort and (E, F) non-Korean cohort.